James P. Flynn - 16 May 2024 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role: Director
Signature: /s/ David M. Urso, as attorney in fact
Issuer symbol: MEIP
Transactions as of: 16 May 2024
Net transactions value: +$24,981
Form type: 4
Filing time: 20 May 2024, 16:00:13 UTC
Previous filing: 21 Mar 2024
Next filing: 29 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MEIP	Common Stock	Award	$24,981	+7,900		$3.16	7,900	16 May 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted-average price. These shares were purchaased in multiple transactions with prices ranging from $3.11 to $3.21 per share. The reporting person undertakes to provide MEI Pharma, Inc., any security holders of MEI Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set in this Form 4.

Content

The price reported is a weighted-average price. These shares were purchaased in multiple transactions with prices ranging from $3.11 to $3.21 per share. The reporting person undertakes to provide MEI Pharma, Inc., any security holders of MEI Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set in this Form 4.